ABVC BioPharma, Inc. (ABVC) has released an update to notify the public and investors about the unregistered sales of equity securities.
The recent issuance of shares and warrants was conducted privately, leveraging exemptions from the standard registration requirements under U.S. securities laws. These securities cannot be sold publicly in the United States without proper registration or an exemption, ensuring that the sale was exclusive and not advertised to the general public.
For further insights into ABVC stock, check out TipRanks’ Stock Analysis page.
For a comprehensive understanding of the announcement, you can read the full document here.
